The early preimplantation embryo relies on mRNA and protein from the oocyte to detect DNA damage and activate DNA repair, cell cycle arrest or apoptosis. Expression of some repair genes has been detected in mammalian oocytes and embryos; however, little is known about DNA repair gene expression in human blastocysts. In this study, DNA repair gene expression was investigated in human oocytes and blastocysts to identify the pathways involved at these stages and detect potential differences in repair mechanisms preand post-embryonic genome activation.
Introduction
DNA repair is responsible for protecting the genome of a cell or organism from endogenous metabolites or exogenous agents causing DNA damage. Various DNA repair proteins act together in elaborate cellular pathways in order to detect and repair different types of DNA lesions, e.g. double strand breaks (DSBs), errors during replication etc. The main DNA repair pathways active in mammalian cells are: base excision repair (BER), direct reversal of damage, double strand break repair (DSBR), mismatch repair (MMR) and nucleotide excision repair (NER). The mechanisms of mammalian DNA repair, overall involving DNA lesion recognition, DNA exonuclease, DNA polymerase and DNA ligase activities, have been reviewed extensively (Christmann et al., 2003; Sancar et al., 2004; Hakem, 2008) . Following DNA damage detection, repair pathways are activated via transient cell cycle arrest (Branzei and Foiani, 2008) ; when a lesion cannot be repaired, cell cycle arrest is either permanently sustained or the apoptotic pathways are triggered to eliminate the cell.
There is not much information available regarding DNA repair in early development of totipotent cells. Some studies on human and murine embryonic stem cells have reported lower mutation frequencies and different mutation types compared with somatic cells (Maynard et al., 2008; Tichy and Stambrook, 2008) , underlining the potential differences of DNA repair mechanisms at these most critical stages of early development.
Overall, DNA repair has been considered a maternal trait. The DNA repair transcripts that have accumulated in the human oocyte play a role during fertilization in controlling changes in chromatin remodelling and maintaining chromatin integrity; experiments on rat and mouse zygotes have indicated recognition of DNA lesions and repair in the paternal chromatin after fertilization (Barton et al., 2007; Derijck et al., 2008) . Subsequent to this, DNA repair is expected to have a major impact on embryo development. It has been shown that human oocytes express DNA repair genes at high levels allowing low tolerance for DNA decays (Menezo et al., 2007) . The maternal transcripts and proteins are expected to support the zygote's development until embryonic genome activation (EGA).
Gene expression profiling of mouse preimplantation embryos showed characteristic patterns of maternal RNA depletion and revealed that EGA happens in two phases: an initial weak transcription from the new zygotic genome followed by major EGA allowing dramatic reprogramming of expression patterns (reviewed by Hamatani et al., 2006) . The factors controlling the reprogramming of the embryonic genome, including DNA methylation and histone acetylation, have been investigated by a large number of studies in recent years and are described in great detail by Bell et al. (2008) and Duranthon et al. (2008) . In humans, EGA occurs at the 4-8-cell stage (Tesarik et al., 1986 (Tesarik et al., , 1987 (Tesarik et al., , 1988 Braude et al., 1988; Telford et al., 1990) .
Although the expression of some DNA repair genes has been detected in mammalian embryos at different stages of development (as reviewed by Jaroudi and SenGupta, 2007) , the ability of the human preimplantation embryo to detect and repair DNA damage has not yet been well described.
Recent developments in RNA amplification methods and microarray technologies make it possible to detect the expression of virtually every gene in the genome from a single sample. In this study, Human Genome Survey Microarrays V2.0 (Applied Biosystems, UK), which interrogate 29 098 genes, were used to investigate human metaphase II (MII) oocytes and blastocysts for the expression of a comprehensive list of genes obtained from a Supplement Table to a review by Wood et al. (2005) . This list included genes coding for DNA repair enzymes, cellular response to DNA damage genes or genes known to be mutated in human diseases associated with DNA sensitivity.
Based on previous expression studies on germinal vesicle (GV) oocytes (Menezo et al., 2007) , we hypothesized that the human oocyte expresses most DNA repair genes to support the early preimplantation embryo and limit DNA damage. There is no evidence indicating whether the blastocyst has a supply of mRNA for DNA repair under routine IVF conditions, without the induction of specific DNA lesions. Due to the high rate of replication and the onset of differentiation in the blastocyst, the expression profile of DNA repair genes may be different to oocytes. Our main aim was to identify the DNA repair pathways that may be active pre-and post-EGA by investigating mRNA in human in vitro matured oocytes and blastocysts, respectively.
In order to allow analysis of the relative differences in gene expression within matured oocytes and blastocysts, FEN1 was used as the reference gene. FEN1 removes 5 0 single-stranded flap structures, which arise during DNA replication, recombination and strand displacement DNA synthesis in BER (Liu et al., 2004) . FEN1 activity is crucial for maintaining the stability of repeat sequences in the genome.
Materials and Methods

Sample collection and processing
Donated immature oocytes and surplus cryopreserved blastocyst embryos were collected from the Assisted Conception Unit (ACU) at University College London Hospital (UCLH). Written consent was obtained from all patients. Immature (MI) oocytes were collected 40 h post hCG injection. The immature oocytes were subsequently kept in culture in G-IVF PLUS medium (Vitrolife, UK) for a maximum of 4 h before rescoring. Nine oocytes that had matured in this time were selected for microarray analysis. Nine slow frozen blastocysts were thawed and allowed to recover in culture prior to collection. Samples were pooled in groups of three oocytes or three blastocysts. The mean maternal age was 35.77 years +4.05. The average age per group ranged between 34 and 37 years (standard deviation ¼ 1.36).
The zona pellucida was removed by brief exposure to acidified Tyrode's solution (Medi-Cult, Surrey, UK) in order to make sure the sample was completely denuded of cumulus cells. Each sample was immediately and thoroughly washed in phosphate buffered saline (PBS, Mg 2þ and Ca 2þ free) (Invitrogen/Gibco, UK) with 0.1% polyvinyl alcohol (PVA) (Sigma, UK) and 0.3 U/ml RNasin w Plus ribonuclease inhibitor (Promega, UK). All manipulations were conducted rapidly to minimize changes in gene expression, although samples were outside of incubators. Samples were transferred in minimum volume (,1 ml) of solution (PBS/PVA þ RNasin) to an empty 0.2 ml MicroAmp reaction tube and stored at 2808C until RNA extraction. The presence of a polar body was confirmed in all oocytes during manipulation, indicating that all immature oocytes had matured into MII oocytes during incubation in the standard culture media, prior to freezing.
Total RNA extraction, amplification and quality assessment Total RNA was extracted from pooled samples using the AllPrep DNA/ RNA Micro kit (Quiagen, Sussex, UK) following the manufacturer's instructions. The purified RNA was then amplified in two rounds and digoxigenin-labelled using the NanoAmp TM RT-IVT Labelling kit (Applied Biosystems, UK). The quality of extracted and amplified RNA was assessed using the NanoDrop w ND-1000 spectrophotometer (Isogen Life Science, Netherlands) and the Agilent 2100 Bioanalyzer (Agilent, CA, USA).
Hybridization, microarray processing, scanning and result analysis
For each sample, 10 mg amplified and digoxigenin-labelled RNA was applied onto a Human Genome Survey Microarray V2.0 (Applied Biosystems, UK), which includes 32 878 oligo probes interrogating 29 098 genes. Hybridization, chemiluminescence detection (using Applied Biosystems' Chemiluminescence detection kit), image acquisition on the Applied Biosystems 1700 Chemiluminescent Microarray Analyzer and initial analysis of the raw data using the Spotfire& Integromics TM AB1700 Application Package were carried out at the Molecular Histopathology laboratory at the Trinity Centre for Health Sciences (St James's Hospital, Dublin, Ireland).
Functional annotations and detection of genes involved in DNA damage response pathways
The Panther online database (http://www.pantherdb.org/) was used for functional annotations (Mi et al., 2005) and a comprehensive list of DNA repair genes was obtained from a Supplement Table to a review by (Wood et al., 2005) updated in February 2008. All genes listed are known to be involved in DNA repair pathways (the online table provides the OMIM links for each gene). Experimental evidence showing functional DNA repair roles of these enzymes can be obtained from the 'database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage' (Friedberg and Meira, 2006) . Twelve commonly used housekeeping genes (Mamo et al., 2007) were investigated as controls and genes shown to be over-expressed in cumulus cells in the human (LHCGR, BMPR2, TNFSF11/RANKL, SEMA3A, C7, CD200) (Assou et al., 2006) and in the mouse (AREG, EREG and BTC) (HernandezGonzalez et al., 2006) were examined to confirm that the oocytes were completely denuded. Three genes associated with pluripotency were investigated: NANOG, POU5F1 (OCT3/4) and SOX2.
Signals from each microarray were filtered prior to analysis to eliminate all probes with a signal to noise (S.N.) ratio ,3 and flags over 5000 from the data sets. Expression levels of all genes were grouped into three main categories (high, medium and low) based on the signal values after removal of the outliers from the data (top and bottom 5% signals detected). Signals were then split into three equal groups; the medium expression level ranged from 7000 to 29 500. A t-test analysis was performed and genes were characterized as differentially expressed for P-values ,0.05.
Results
RNA samples quality
The amount of total RNA obtained from each group of three blastocysts or MII oocytes ranged from 63 to 246 pg/ml for blastocysts and from 48 to 52 pg/ml for MII oocytes. These concentrations increased after two rounds of amplification to the following ranges: 91 ng/ml to 1 mg/ml for blastocysts and 134 -292 ng/ml for oocytes. All samples used were of good quality according to our Nanodrop and Bioanalyzer results.
General expression analysis
Out of the 32 878 oligo probes investigated, the total number detected was 13 118 and 11 734 in the blastocysts and oocytes, respectively. None of the genes previously shown to be overexpressed in cumulus cells could be detected in any sample with the exception of BTC, which was picked up at very low levels (near the limit of detection) in both oocytes, and blastocysts and BMPR2 which had moderate expression level in oocytes and low levels in blastocysts. Eleven out of the 12 housekeeping genes investigated were detected in both oocytes and blastocysts; BMP7 was not detected in either sample sets. Three genes (UBC, EEF1E1 and TUBB4) did not show significant differences in expression levels; however, five genes (PPIA, HIST2H2AA, ACTB, GAPDH and H2AFZ) showed a greater than 3-fold increase in the blastocyst group compared with the oocyte group and three showed a greater than 3-fold decrease in the blastocyst group versus the oocyte group. Regarding genes associated with pluripotency, NANOG and POU5F1 (OCT3/4) mRNAs were detected in high levels in the blastocysts. Only POU5F1 was detected in MII oocytes with low expression levels. SOX2 was not detected in either sample sets.
Expression of DNA repair genes in the MII oocyte and blastocyst Of the 154 DNA repair genes investigated, 153 were identified by probes on the Applied Biosystems Human Genome Survey Microarrays V2.0. mRNAs coding for 109 of those genes were detected in blastocysts (the remaining 43 had S.N. ratios ,3 in at least one of the replicates) and 107 of those genes were detected in oocytes. Eighty nine (89) of these DNA repair genes were common to both the oocyte and blastocyst groups. No DNA repair gene probes were excluded when the top and bottom 5% signals were eliminated from the data. The DNA repair genes and their expression levels in both MII oocytes and blastocyst embryos are listed in Supplementary Table I) .
As would be expected, distinctive expression patterns were observed in the MII oocyte and blastocyst groups. Overall, 129 DNA repair genes were included in a t-test analysis and 55 were found to be differentially expressed in blastocysts compared with oocytes with fold change .3 (P , 0.05). Among the differentially expressed DNA repair genes, 40 genes (73%) had significantly lower expression levels in the blastocyst group versus the oocyte group, whereas only 15 (27%) had significantly higher expression levels. All differentially expressed DNA repair genes are listed with their corresponding fold changes in Supplementary Tables II and III. The mRNA expression levels of highly expressed genes involved in the main repair pathways, relative to the structure specific flap endonuclease-1 (FEN1) gene, are illustrated in Fig. 1 .
Discussion
All DNA repair pathways were represented in human oocytes and blastocysts. However, most differentially expressed DNA repair genes were detected at lower levels in the blastocyst compared with the oocyte. This may be because the oocyte must have sufficient mRNA templates to support genome integrity until EGA. The overall repair capacity in the human oocyte or blastocyst is complex as there is a level of redundancy between different repair pathways and many DNA repair proteins are also involved in other cellular pathways. Variations in gene expression levels do not necessarily correlate with DNA repair ability as not all mRNA templates detected are fully translated to functional proteins; however, gene expression is one of the key mechanisms that can influence DNA repair activity. This article provides an overview of DNA repair gene expression in MII oocytes and in blastocysts.
Base excision repair
BER removes damaged DNA bases that are generally induced by reactive oxygen species (ROS). Most of the BER genes examined were expressed in both MII oocytes and blastocysts (Supplementary Table I ). UNG, APEX1 and POLB mRNAs were detected at high levels in both human oocytes and blastocysts. This agrees with microarray data from another group reporting that UNG, APEX1 and POLB are highly expressed in human oocytes at the GV stage (Menezo et al., 2007) given that the mRNA content in the oocyte does not change between the GV and the MII stage as there is no transcription at the final stages of oocyte maturation (El Mouatassim et al., 1999) . Degradation of some mRNA transcripts may occur, which may explain the lower number of transcripts picked up in MII oocytes versus GVs (Fair et al., 2007; Wells and Patrizio, 2008) . Our data showed that OGG1 mRNA was detected at medium levels in the MII oocytes and low levels in the blastocysts (Supplementary  Table I ); Menezo et al. (2007) also detected medium expression levels of OGG1 in human GV oocytes. The low expression levels of OGG1 mRNA in the blastocyst may indicate that despite the high levels of APEX1 mRNA, and POLB (which plays other key roles in Expression profiling of DNA repair genes the cell), BER of 8-oxoguanine residues is probably not as important in the blastocyst as it is in the oocyte.
Double-strand break repair
Two sub pathways are involved in the repair of DSBs: homologous recombination (HR) and non-homologous end-joining (NHEJ) (Haber, 2000; Johnson and Jasin, 2000; Cromie et al., 2001) . Overall, mRNA templates coding for 12/19 genes involved in HR repair and 3/6 genes involved in NHEJ were detected in both the MII oocyte and blastocyst groups (Supplementary Table I ). Thus DSBR via the HR pathway seems to be active in MII oocytes and blastocysts. This is expected for the oocytes (as HR is active during M phase) and for the blastocysts since HR has greater fidelity of DNA repair than NHEJ and thus may be the preferred mechanism for DSBR. The short G1 and G2 phases in rapidly dividing blastomeres support the assumption that HR is the dominant DSBR mechanism in the blastocyst. The first step in HR involves RAD52, which competes with KU to direct DSBR toward HR rather than NHEJ (Van Dyck et al., 1999; Bassing and Alt, 2004) . RAD52 was highly expressed in MII oocytes and blastocysts. HR in mammalian cells is highly dependent on the MRE11A-RAD50-NBS1 (MRN) complex which binds DNA, and the exonuclease EXO1. These genes were expressed in higher levels in human MII oocytes compared with blastocysts. RAD51, another HR repair gene with ATPase activity, was expressed at high levels in both groups. The interaction of BRCA2 with RAD51 activates repair using HR (via the cyclin-dependent kinase (CDK) regulatory pathway). mRNA expression of BRCA2 was only detected in the MII oocytes (medium level). BRCA2 expression has also been detected in human GV oocytes at medium levels (Menezo et al., 2007) and in human MII oocytes with lower levels in preimplantation embryos (increasing from 2-cell to the blastocyst stage) (Wells et al., 2005) . The interaction of FANCD2 or FANCI with BRCA1 also triggers HR [via ATR (Ataxia telangiectasia and Rad3 related) regulation]. FANCD2 mRNA expression levels were significantly higher in the blastocyst versus the oocyte group (P , 0.05 and 4.3-fold increase) (Supplementary Table III) . BRCA1 mRNA expression was detected at medium levels in the blastocysts but was not detected in MII oocytes. This is contrary to data by Menezo et al. (2007) , where BRCA1 was shown to be expressed at high levels in human GV oocytes, and previous studies revealed that BRCA1 was expressed in human MII oocytes at higher levels than in blastocysts (Wells et al., 2005) . The main activation processes of DSBR via HR may be different in the blastocyst and oocyte, which would explain the differences in expression levels of various genes. The NHEJ genes XRCC5 (Ku70) and XRCC6 (Ku80) had medium to high expression levels in the MII oocytes and blastocysts (Supplementary Table I ); with significantly higher XRCC5 (Ku70) mRNA levels (P , 0.05 and 37-fold greater) in the blastocyst group versus the oocyte group (Supplementary  Table III) . XRCC4, had high and medium mRNA expression levels in MII oocytes and blastocysts, respectively. LIG4 expression, however, could not be detected in either group (LIG4 was detected in low levels in only two out of the three MII oocyte replicates). DCLRE1C (Artemis) was only expressed in the blastocysts. During S phase, NHEJ and HR proteins can compete over binding of DSBs. It has been suggested that RAD18 and PARP1 may suppress the DNA binding of KU proteins in favour of HR (Saberi et al., 2007) . PARP1 showed higher mRNA expression levels in blastocysts versus MII oocytes (but the difference was not statistically significant) and RAD18 mRNA was only detected in the blastocysts. 
Mismatch repair
MMR is the main DNA repair pathway active post DNA replication (G2/M checkpoint). The main MMR genes (MLH1, MSH2, MSH3, MSH6, PMS1 and PMS2) were expressed in human MII oocytes and blastocysts (Supplementary Table I ). MSH3 was expressed at low levels in the human blastocysts and at medium levels in the oocytes; although MLH1, MSH2 and MSH6 were highly expressed in both sample groups. Elevated MSH2 and MSH6 expression levels have been reported in GV oocytes and it was hypothesized that 8-oxo nucleotides are removed via the MMR pathway rather than the more common OOG1 pathway (Menezo et al., 2007) . Three of the key MMR genes (MSH2, MSH3 and PMS1) were expressed at significantly higher levels in the human MII oocytes versus the blastocysts (Supplementary Table II ). This may indicate that whereas MMR activity may be important in the human blastocyst, it is of greater significance for the oocyte and early preimplantation embryo that avoid apoptosis as cell death at these stages reduces the chances of survival of the embryo. However, recognition of mismatched DNA may lead to activation of apoptosis in the blastocyst. In fact, apoptosis is commonly observed in some cells at the late cleavage or blastocyst stages while there is no indication of apoptosis in the normally developing human embryo prior to compaction (Antczak and van Blerkom, 1999; Hardy, 1999; Haouzi et al., 2008) . Our data showed that the anti-apoptotic genes BCL-2 and BCL-W were both expressed at low levels in human MII oocytes and blastocysts and BCL-XL was not detected in either group. The pro-apoptotic genes BAX and BAK were expressed at low levels in MII oocytes and medium levels in the blastocysts. BAD (another pro-apoptotic gene from the BCL-2 family) was only detected in the blastocysts. Although the expression levels of pro-apoptotic genes were higher in blastocysts than in MII oocytes, the differences were not statistically significant.
Nucleotide excision repair
mRNA transcripts coding for 18 NER genes were detected in both MII oocytes and blastocysts some of which showed differential expression between the two groups (see Supplementary Table I for full list of genes). Most were significantly higher in the MII oocytes compared with the blastocysts, specifically the kinase subunits of TFIIH CDK7, CCNH, MNAT1 as well as RPA1, ERCC6 (CSB) and LIG1 (Supplementary Table II) . Only RAD23B had significantly higher mRNA levels in the blastocyst group (Supplementary Table III) . Genes involved in the transcription-coupled repair (TCR) pathway, ERCC6 (CSB), GTF2H1, 2 & 5 and MMS19L, had medium or high mRNA expression levels in the human MII oocyte. These TCR genes were found to be highly expressed in the human GV oocytes (Menezo et al., 2007) . Although there is no transcription before the 4-cell stage (Braude et al., 1988; Telford et al., 1990) , the mRNA transcripts laid down for the TCR proteins may be translated and used in the preimplantation embryo when it begins its own transcription processes. As NER is active during G1 phase of the cell cycle, the mRNA templates found in the oocytes are most likely solely stored for translation and used by the early preimplantation embryo. The G1 phase is also short in rapidly dividing cells of the blastocyst; this may mean that NER is rather limited in these cells as well.
Other DNA repair pathways
The three genes involved in direct reversal of DNA damage ALKBH2 (ABH2), DEPC-1 and MGMT were all expressed in MII oocytes and blastocysts. The DNA-protein cross-links repair gene TDP1 had high mRNA expression levels picked up in the MII oocytes and low levels in the blastocysts (Supplementary Table I ).
Conclusion
The data from this study shows that both oocytes and embryos can potentially carry out all types of repair. Expression levels of DNA repair genes at the transcriptional level pre-and post-EGA suggest differences in DNA repair mechanisms at these developmental stages. Investigation of the BER pathway indicated greater protection against free radicals pre-EGA versus post-EGA. The main pathway for DSBR appears to be HR but the activation of the pathway may be different between the blastocyst and the oocyte. Expression of the MMR genes in MII oocytes indicates that the pathway is directed towards repair rather than apoptosis. In blastocysts, however, MMR genes were expressed at significantly lower levels than in MII oocytes although the pro-apoptotic genes were expressed at similar levels. The oocyte has all the mRNA transcripts required for NER; however, post EGA the role of this pathway may be limited as the levels of expression of most NER genes were lower in the blastocyst compared with the oocyte. This is expected, as the G1 phase is short in the cells of the blastocyst.
The expression patterns detected in the oocytes used in this study will be influenced by a variety of factors, including stimulation protocols, partial immaturity at retrieval and culture conditions. For the blastocysts, the effects of cryopreservation also need to be considered. Despite any changes in gene expression that may have occurred, it seems that all DNA repair pathways are potentially functional in the human MII oocytes and blastocyst embryos, as a large number of DNA repair genes involved in different repair pathways are expressed at these stages. Possibly, as the maternal transcripts decline before EGA, there may be a stage during which the embryo is more vulnerable to DNA damage. Further microarray analysis of embryos at each stage of development up to the blastocyst stage may identify potential vulnerabilities.
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